ycliper

Популярное

Музыка Кино и Анимация Автомобили Животные Спорт Путешествия Игры Юмор

Интересные видео

2025 Сериалы Трейлеры Новости Как сделать Видеоуроки Diy своими руками

Топ запросов

смотреть а4 schoolboy runaway турецкий сериал смотреть мультфильмы эдисон
Скачать

Safety of biologics for the treatment of psoriasis

Автор: Dermatology Education

Загружено: 2016-09-23

Просмотров: 14812

Описание: Successful management of psoriasis requires effective long-term treatment. Dr Kristian Reich shares his insights into the risk-benefit profiles of biologic medications using examples from pooled analyses of long-term clinical trial data and patient registries, and discusses the relative merits of interpreting each approach to long-term data analysis.

Find out more at: http://www.dermatology-education.com/...
View Dr Kristian Reich's profile at: http://www.dermatology-education.com/...

Dermatology Education is directed by internationally renowned experts in dermatology who will provide regular clinical perspectives on the latest publications, congress presentations, treatment guidelines and other information addressing the challenges faced by dermatologists in the clinic.

The views expressed here are those of the contributors and do not reflect those of either FIDE or The Fishawack Group of Companies. The content has been developed for specialist dermatologists only. It is intended to help them with their own professional development and research and should not be relied upon for making individual clinical decisions, which are the responsibility of the treating clinicians.

Participation by Professor Kristian Reich in this activity does not constitute or imply endorsement by the Georg-August-University or the Dermatologikum Hamburg.

Не удается загрузить Youtube-плеер. Проверьте блокировку Youtube в вашей сети.
Повторяем попытку...
Safety of biologics for the treatment of psoriasis

Поделиться в:

Доступные форматы для скачивания:

Скачать видео

  • Информация по загрузке:

Скачать аудио

Похожие видео

Taltz

Taltz

Inhibition of the IL-17A receptor with brodalumab for the treatment of psoriasis

Inhibition of the IL-17A receptor with brodalumab for the treatment of psoriasis

Ixekizumab vs. guselkumab in plaque psoriasis, A. Blauvelt et al

Ixekizumab vs. guselkumab in plaque psoriasis, A. Blauvelt et al

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

IL-23 Inhibitors and Other Emerging Psoriasis Treatments

Using Biologics to Manage Moderate to Severe Atopic Dermatitis

Using Biologics to Manage Moderate to Severe Atopic Dermatitis

Себорейный дерматит. Самое главное

Себорейный дерматит. Самое главное

Psoriasis and beyond: targeting the IL-17 pathway

Psoriasis and beyond: targeting the IL-17 pathway

Living with psoriasis: Reena's journey

Living with psoriasis: Reena's journey

Лечение псориаза: подходят ли вам таблетки от псориаза?

Лечение псориаза: подходят ли вам таблетки от псориаза?

Biologics for Psoriasis: One Life Changed | WebMD

Biologics for Psoriasis: One Life Changed | WebMD

Biologics in Plaque Psoriasis

Biologics in Plaque Psoriasis

Открытие Варбурга: 4 переключателя, которые мешают раку расти | Здоровье с Доктором

Открытие Варбурга: 4 переключателя, которые мешают раку расти | Здоровье с Доктором

Cosentyx

Cosentyx

Risankizumab vs. Ustekinumab for Psoriasis

Risankizumab vs. Ustekinumab for Psoriasis

FAQs Psoriasis Injection Treatment (Part 1) | Secukinumab Scapho

FAQs Psoriasis Injection Treatment (Part 1) | Secukinumab Scapho

Ixekizumab for the treatment of psoriasis

Ixekizumab for the treatment of psoriasis

Understanding Psoriasis: Causes, Symptoms, and Effective Treatments

Understanding Psoriasis: Causes, Symptoms, and Effective Treatments

Comparative effectiveness of biologic agents for the treatment of psoriasis

Comparative effectiveness of biologic agents for the treatment of psoriasis

Tremfya

Tremfya

Biologics Therapy for Psoriasis

Biologics Therapy for Psoriasis

© 2025 ycliper. Все права защищены.



  • Контакты
  • О нас
  • Политика конфиденциальности



Контакты для правообладателей: [email protected]